Literature DB >> 16468718

Correlation of F0F1-ATPase inhibition and antiproliferative activity of apoptolidin analogues.

Paul A Wender1, Orion D Jankowski, Kate Longcore, Elie A Tabet, Haruo Seto, Taijiro Tomikawa.   

Abstract

[structure: see text] Apoptolidin (1) exhibits potent and highly selective apoptosis inducing activity against sensitive cancer cell lines and is hypothesized to act by inhibition of mitochondrial F(0)F(1)-ATP synthase. A series of apoptolidin derivatives, including a new intermolecular Diels-Alder adduct, were analyzed for antiproliferative activity in E1A-transformed rat fibroblasts. Potent F(0)F(1)-ATPase inhibition was not a sufficient determinant of antiproliferative activity for several analogues, suggesting the existence of a secondary biological target or more complex mode of action for apoptolidin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16468718      PMCID: PMC2533578          DOI: 10.1021/ol052800q

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  19 in total

1.  Total synthesis of apoptolidin: completion of the synthesis and analogue synthesis and evaluation.

Authors:  K C Nicolaou; Yiwei Li; Kazuyuki Sugita; Holger Monenschein; Prasuna Guntupalli; Helen J Mitchell; Konstantina C Fylaktakidou; Dionisios Vourloumis; Paraskevi Giannakakou; Aurora O'Brate
Journal:  J Am Chem Soc       Date:  2003-12-17       Impact factor: 15.419

2.  Facile synthetic access to and biological evaluation of the macrocyclic core of apoptolidin.

Authors:  Paul A Wender; Orion D Jankowski; Elie A Tabet; Haruo Seto
Journal:  Org Lett       Date:  2003-06-26       Impact factor: 6.005

3.  Enantioselective synthesis of apoptolidinone: exploiting the versatility of thiazolidinethione chiral auxiliaries.

Authors:  Michael T Crimmins; Hamish S Christie; Kleem Chaudhary; Alan Long
Journal:  J Am Chem Soc       Date:  2005-10-12       Impact factor: 15.419

4.  Apoptolidin, a new apoptosis inducer in transformed cells from Nocardiopsis sp.

Authors:  J W Kim; H Adachi; K Shin-ya; Y Hayakawa; H Seto
Journal:  J Antibiot (Tokyo)       Date:  1997-07       Impact factor: 2.649

5.  Structure-activity relationships within a family of selectively cytotoxic macrolide natural products.

Authors:  A R Salomon; Y Zhang; H Seto; C Khosla
Journal:  Org Lett       Date:  2001-01-11       Impact factor: 6.005

6.  Apoptolidin, a selective cytotoxic agent, is an inhibitor of F0F1-ATPase.

Authors:  A R Salomon; D W Voehringer; L A Herzenberg; C Khosla
Journal:  Chem Biol       Date:  2001-01

7.  Understanding and exploiting the mechanistic basis for selectivity of polyketide inhibitors of F(0)F(1)-ATPase.

Authors:  A R Salomon; D W Voehringer; L A Herzenberg; C Khosla
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

8.  Apoptolidins B and C: isolation, structure determination, and biological activity.

Authors:  Paul A Wender; Martin Sukopp; Kate Longcore
Journal:  Org Lett       Date:  2005-07-07       Impact factor: 6.005

9.  ATP depletion rather than mitochondrial depolarization mediates hepatocyte killing after metabolic inhibition.

Authors:  A L Nieminen; A K Saylor; B Herman; J J Lemasters
Journal:  Am J Physiol       Date:  1994-07

10.  Enantioselective preparation of the C1-C11 fragment of apoptolidin.

Authors:  William D Paquette; Richard E Taylor
Journal:  Org Lett       Date:  2004-01-08       Impact factor: 6.005

View more
  11 in total

1.  Biosynthesis of the Apoptolidins in Nocardiopsis sp. FU 40.

Authors:  Yu Du; Dagmara K Derewacz; Sean M Deguire; Jesse Teske; Jacques Ravel; Gary A Sulikowski; Brian O Bachmann
Journal:  Tetrahedron       Date:  2011-09-02       Impact factor: 2.457

Review 2.  Natural products and other inhibitors of F1FO ATP synthase.

Authors:  Bhargav A Patel; Terin L D'Amico; Brian S J Blagg
Journal:  Eur J Med Chem       Date:  2020-09-03       Impact factor: 6.514

Review 3.  Applications of Nonenzymatic Catalysts to the Alteration of Natural Products.

Authors:  Christopher R Shugrue; Scott J Miller
Journal:  Chem Rev       Date:  2017-06-05       Impact factor: 60.622

4.  Light-induced isomerization of apoptolidin a leads to inversion of C2-C3 double bond geometry.

Authors:  Brian O Bachmann; Ruth McNees; Bruce J Melancon; Victor P Ghidu; Rachel Clark; Brenda C Crews; Sean M Deguire; Lawrence J Marnett; Gary A Sulikowski
Journal:  Org Lett       Date:  2010-07-02       Impact factor: 6.005

5.  Mitochondrial Side Effects of Surgical Prophylactic Antibiotics Ceftriaxone and Rifaximin Lead to Bowel Mucosal Damage.

Authors:  Bálint Baráth; Dávid K Jász; Tamara Horváth; Bence Baráth; Gergely Maróti; Gerda Strifler; Gabriella Varga; Lilla Sándor; Domonkos Perényi; Szabolcs Tallósy; Tibor Donka; Péter Jávor; Mihály Boros; Petra Hartmann
Journal:  Int J Mol Sci       Date:  2022-05-03       Impact factor: 6.208

6.  Apoptolidins E and F, new glycosylated macrolactones isolated from Nocardiopsis sp.

Authors:  Paul A Wender; Kate E Longcore
Journal:  Org Lett       Date:  2009-12-03       Impact factor: 6.005

7.  An approach to the site-selective diversification of apoptolidin A with peptide-based catalysts.

Authors:  Chad A Lewis; Kate E Longcore; Scott J Miller; Paul A Wender
Journal:  J Nat Prod       Date:  2009-10       Impact factor: 4.050

8.  Combined chemical and biosynthetic route to access a new apoptolidin congener.

Authors:  Victor P Ghidu; Ioanna Ntai; Jingqi Wang; Aaron T Jacobs; Lawrence J Marnett; Brian O Bachmann; Gary A Sulikowski
Journal:  Org Lett       Date:  2009-07-16       Impact factor: 6.005

9.  Synthesis and evaluation of the cytotoxicity of apoptolidinones A and D.

Authors:  Victor P Ghidu; Jingqi Wang; Bin Wu; Qingsong Liu; Aaron Jacobs; Lawrence J Marnett; Gary A Sulikowski
Journal:  J Org Chem       Date:  2008-06-11       Impact factor: 4.354

Review 10.  Why All the Fuss about Oxidative Phosphorylation (OXPHOS)?

Authors:  Yibin Xu; Ding Xue; Armand Bankhead; Nouri Neamati
Journal:  J Med Chem       Date:  2020-10-26       Impact factor: 8.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.